Dr. Tanvi Parikh

After graduating top of her class in B J Medical College, Pune, Dr Parikh completed her Internal Medicine as well as Endocrinology, Diabetes and Metabolism training in the US;  at premier institutes such as Georgetown University and the National Institutes of Health,  Washington, DC. She went on to work as a consultant endocrinologist in the US. She has returned to practice in Pune after spending 7 years in the US. Her goal is to work towards improving management of hormonal disorders in India by providing evidence-based, comprehensive and personalized care. 

• Endocrinology Society of India (ESI)
• Indian Medical Association(IMA)
• Maharashtra Medical Council(MMC)
• American Endocrine Society (ENDOSOC)   
• American Thyroid Association (ATA) 
• American Association of Clinical Endocrinologists (AACE) 
• American College of Physicians (ACP)  

• Dual Endocrinopathies following single dose of Pembrolizumab therapy, Journal of Endocrine Society 2019 Apr 15; Volume 3 (Suppl 1)
• Refractory Thyroid Storm: Role of Single Pass Albumin Dialysis (SPAD), Journal of Endocrine Society, Volume 3,  Supplement - 1, April 2019 
• Advanced Thyroid Carcinoma: Targeting the Elderly?  88^th Meeting of the American Thyroid A ssociation October 2018, Washington, D.C, USA
• Papillary Thyroid Cancer within a Thyroglossal Duct Cyst. 88th Meeting of the American Thyroid Association; October 2018, Washington, D.C, USA
• Hypocalcaemia following Magnesium Infusion in Pre-eclampsia – an Under-recognized Phenomenon. 100th Meeting of Endocrine Society; March 2018 Chicago, USA
• Normo-calcemic Primary Hyperparathyroidism leading to Non-Uremic Calciphylaxis. 99th Meeting of the Endocrine Society; April 2017, Orlando, Florida, USA
• Small gland, big trouble – Post-Partum Sub acute Onset Idiopathic Pan-hypopituitarism. 99th Meeting of the Endocrine Society; April 2017 Orlando, Florida, USA
• Spontaneous Intra- thyroid Hemorrhage precipitated by Anticoagulation therapy resulting in acute respiratory failure. 86th Meeting of the American Thyroid Association; September 2016, Denver, Colorado, USA
• Retrospective study comparing Clinical, Pathologic and Molecular characteristics of RAI-avid vs. RAI-refractory metastatic differentiated thyroid cancer.
• Prospective study aiming to validate use of DNA PCR assays of BRAFV600 and RAS oncogene mutations as blood biomarkers of efficacy of treatment and prognosis in metastatic thyroid cancer. 
• Quality improvement project aiming to determine what percentage of hypothyroid patients meet their TSH goal within first 6 months of starting levothyroxine therapy. 

Prestigious Presidential Poster award for Outstanding Research Abstract, awarded to only one endocrinology trainee per year at American Endocrine Society Conference, in New Orleans, USA, in March 2019

Young Investigator Travel Award for best poster abstract at American Association of Clinical Endocrinology Conference, in 2019

Day: Mon/Wed/Fri

Timing: 10:00am to 11:30pm